These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Clinical experience report on Hepavis]. Menninger U, Menninger W. Med Welt; 1980 Oct 17; 31(42):1519-21. PubMed ID: 7453534 [No Abstract] [Full Text] [Related]
4. [Treatment with Hepavis, a new cholerectically-active hepaticum. Experiences from an internal medicine profemoral practice]. Stuchlik S. Med Monatsschr; 1977 Nov 17; 31(11):524-6. PubMed ID: 927326 [No Abstract] [Full Text] [Related]
5. [Treatment of alcoholic toxic fatty liver. A placebo-controlled trial with hepavis (author's transl)]. Deynet G, Reimer F. MMW Munch Med Wochenschr; 1979 Jun 15; 121(24):831-2. PubMed ID: 111085 [Abstract] [Full Text] [Related]
6. [Does Hepavis have value in the therapy of fatty liver caused by alcohol poisoning?]. Odegaard S, Busch D. Z Gastroenterol; 1989 Feb 15; 27(2):91-3. PubMed ID: 2658394 [Abstract] [Full Text] [Related]
7. [Repair, regeneration and metabolism of liver cells: a clinical report]. Blasy J. ZFA (Stuttgart); 1979 Apr 30; 55(12):787-91. PubMed ID: 375610 [No Abstract] [Full Text] [Related]
17. [Clinical trial of a new hepatoprotective preparation]. Azzena D. Clin Ter; 1972 Jan 31; 60(2):143-8. PubMed ID: 5015349 [No Abstract] [Full Text] [Related]
18. [The treatment of vascular diseases with a magnesium containing drug (Progresin)]. Straube G. Z Allgemeinmed; 1975 Mar 27; 51(9):450-5. PubMed ID: 1163068 [No Abstract] [Full Text] [Related]
19. [Therapeutic effect of a preparation of total liver extract, cyanocobalamin and amino acids of the Krebs cycle, in acute and chronic liver diseases]. Pignattari S, Sarti F, Toscano S, Dal Monte PR. Minerva Med; 1972 Jul 11; 63(53):2861-72. PubMed ID: 5049878 [No Abstract] [Full Text] [Related]